UK markets open in 6 hours 54 minutes

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.0900-0.1200 (-3.74%)
At close: 04:00PM EDT
3.1900 +0.10 (+3.24%)
After hours: 07:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
28,941
33,879
43,107
30,168
15,141
-
Cost of revenue
12,052
13,827
15,827
12,557
9,508
-
Gross profit
16,889
20,052
27,280
17,611
5,633
-
Operating expenses
Research development
9,803
9,861
15,996
14,422
11,470
-
Selling general and administrative
40,679
41,837
37,775
38,406
27,476
-
Total operating expenses
44,116
45,332
53,771
52,828
38,946
-
Operating income or loss
-27,227
-25,280
-26,491
-35,217
-33,313
-
Interest expense
-
-
-
-
-
-1,062
Total other income/expenses net
-3,130
-1,626
-11,067
-946
-15,064
-
Income before tax
-30,006
-26,292
-37,431
-35,842
-47,511
-
Income tax expense
-81
-81
1,980
0
0
-
Income from continuing operations
-29,956
-26,259
-40,257
-35,842
-47,511
-
Net income
-30,457
-26,938
-41,014
-36,654
-48,287
-
Net income available to common shareholders
-30,479
-26,960
-41,014
-36,654
-48,287
-
Basic EPS
-3.01
-
-3.01
-2.69
-4.37
-4.80
Diluted EPS
-3.01
-
-3.01
-2.69
-4.37
-4.80
Basic average shares
13,647
-
13,647
13,610
11,045
9,595
Diluted average shares
13,647
-
13,647
13,610
11,045
9,595